Generalized Myasthenia Gravis

Also known as: Myasthenia Gravis, Generalized / Myasthenia Gravis Generalised

DrugDrug NameDrug Description
DB01257EculizumabA recombinant humanized monoclonal antibody used to reduce the risk of hemolysis in paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).
DB15270Efgartigimod alfaA neonatal Fc receptor blocker used to treat generalized myasthenia gravis in patients who are AChR-antibody positive.
DB06205Hyaluronidase (human recombinant)An enzyme used to improve the absorption and dispersion of parenterally administered fluids, drugs, and contrast agents.
DB11580RavulizumabA monoclonal antibody used to treat paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis.
DB14919RozanolixizumabA humanized monoclonal antibody targeting the human neonatal Fc receptor (FcRn) used to treat generalized myasthenia gravis.
DB15636ZilucoplanA complement inhibitor used to treat generalized myasthenia gravis in anti-acetylcholine receptor (AChR) antibody-positive adults.
DrugDrug NamePhaseStatusCount
DB08895Tofacitinib0Recruiting1
DB00531Cyclophosphamide2Not Yet Recruiting1
DB01073Fludarabine2Not Yet Recruiting1
DB06273Tocilizumab2Recruiting1
DB18012Vemircopan2Active Not Recruiting1
DB15636Zilucoplan2Completed1
DB16994CV-MG012 / 3Withdrawn1
DB14919Rozanolixizumab2 / 3Not Yet Recruiting1
DB06273Tocilizumab2 / 3Recruiting1
DB15636Zilucoplan2 / 3Not Yet Recruiting1
DB11640Amifampridine3Completed1
DB16104Batoclimab3Recruiting1
DB16121Cemdisiran3Recruiting1
DB01257Eculizumab3Completed1
DB15270Efgartigimod alfa3Completed2
DB00028Human immunoglobulin G3Completed1
DB00688Mycophenolate mofetil3Completed2
DB15218Pozelimab3Recruiting1
DB11580Ravulizumab3Completed1
DB11580Ravulizumab3Recruiting1
DB00073Rituximab3Recruiting1
DB00073Rituximab3Unknown Status1
DB14919Rozanolixizumab3Active Not Recruiting1
DB14919Rozanolixizumab3Completed3
DB15762Satralizumab3Recruiting1
DB09153Sodium chloride3Unknown Status1
DB18312Telitacicept3Recruiting1
DB15636Zilucoplan3Active Not Recruiting2
DB15636Zilucoplan3Completed1
DB15270Efgartigimod alfaNot AvailableApproved for Marketing1